Amsterdam

• An extension study to investigate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chr … Pending
  2025-522983-33-00 5 Chronic rhinosinusitis with nasal polyps
• Boosting osimertinib Blood Brain Barrier penetration in patients with epidermal growth factor receptor mutated non-small cell lung cancer (O … Pending
  2025-523033-26-00 4 Patients with EGFR-mutated metastatic NSCLC, without CNS metastases on
• A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis Pending
  2025-523127-21-00 3 Rheumatoid Arthritis
• PREOPANC-6 study: dendritic cell immunotherapy after FOLFIRINOX chemotherapy in patients with resectable pancreatic cancer Pending
  2025-523134-28-00 10 ABC borderline resectable pancreatic cancer
• SHIELD – Swift Hydrocortisone Intervention after trauma exposure Pending
  2025-523350-13-02 4 Posttraumatic Stress Disorder (PTSD)
• Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending
  2025-523400-72-00 4 Cystic fibrosis
• A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients with Advanced KRAS … Pending
  2025-523432-39-01 9 Advanced KRAS G12D-Mutant Solid Tumors
• A study of pelabresib and ruxolitinib compared to placebo and ruxolitinib in adult patients with myelofibrosis who have not received prior t … Pending
  2025-523555-66-00 5 Myelofibrosis
• A study to learn more about how safe BAY 3771249 is and how well it works in people with advanced or metastatic colorectal cancer that has a … Pending
  2025-523648-11-00 3 adenocarcinoma of the colon or rectum
• A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3 … Pending
  2025-523674-16-00 5 Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F … Pending
  2025-523675-39-00 5 Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate r … Pending
  2025-524005-32-00 4 Rheumatoid arthritis
• Methotrexate in paediatric and adolescent Crohn’s disease: an observational study Pending
  2025-524129-42-00 6 Crohn’s disease
• A randomized, placebo-controlled trial to assess the efficacy, tolerability, and pharmacokinetics of clemastine in children and adults with … Pending
  2025-524195-29-00 4 Pitt-Hopkins syndrome
• Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an … Pending
  2025-524229-41-00 5 Triple negative breast cancer
• A short treatment with immunotherapy instead of radiotherapy in early-stage lung cancer Pending
  2025-524305-32-00 4 Stage I non-small cell lung cancer
• MERCURE study: MEthotrexate in ReCurrent dVIN Pending
  2025-524373-17-00 6 dVIN caused by Lichen Sclerosus
• The RJVA-001 First in Human Trial in Adults with Inadequately Controlled Type 2 Diabetes. Pending
  2025-524438-24-00 7 Type 2 Diabetes
• Comparison of standard abiraterone dosing and dosing based on abiraterone blood levels Pending
  2025-524440-35-00 6 metastatic castration resistant prostate cancer (mCRPC)
• BIOlogical treatment GRAdual Interval Longing in severe Asthma (BIO-GRAIL) Pending
  2025-524741-28-00 6 Severe Asthma
• Dual-agent fluorescence-guided surgery for colorectal liver metastases Pending
  2025-524755-31-00 10 Colorectal liver metastases
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• A clinical study investigating modafinil for the treatment of severe fatigue in patients with inflammatory bowel disease (MODIFI-IBD trial) Pending
  2026-525163-41-00 10 Inflammatory bowel disease

Showing 73–96 of 1,127 trials